INVIVOSCRIBE INC.

In News

System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows - Business Wire

Business Wire - Apr 15, 2026

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification - Business Wire

Business Wire - Mar 26, 2026

European Commission Approves Astellas' XOSPATA™ for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay - Devdiscourse

Devdiscourse - May 14, 2026

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide - Business Wire

Business Wire - Feb 05, 2026

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China - PR Newswire

PR Newswire - Feb 23, 2023

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Via TT

Via TT - Apr 22, 2025

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - Business Wire

Business Wire - Jul 08, 2025

Blood Cancer Diagnostics Market Size, Trends & Share by 2033 - Straits Research

Straits Research - Jun 23, 2025

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Cancer Biomarkers Market: Growth, Size, Share, and Trends - MarketsandMarkets

MarketsandMarkets - Mar 30, 2016

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment